Skip to content
How to build a state or regional advocacy arm
Patient stories and relationships are at the heart of state advocacy. “A lot of policymakers are just not aware of what our companies are, […]
How to build a state or regional advocacy arm Read More »
Health
Katie Couric on patient advocacy, breast cancer, and biotech
On June 6, the 2023 Biotechnology Innovation Organization (BIO) International Convention opened with remarks by Katie Couric who, in addition to being an award-winning
Katie Couric on patient advocacy, breast cancer, and biotech Read More »
Cure announces $1 million boost to harness AI in finding groundbreaking treatments for critical illnesses
A $1 million project to find groundbreaking treatments for critical illnesses using Artificial Intelligence (AI) has been announced at the 2023 Biotechnology Innovation Organization
Vaccine manufacturing in Africa: challenges and opportunities
COVID was unequivocal in how it shined a light onto profound global health inequity and access issues. And nowhere was that more clear than
Vaccine manufacturing in Africa: challenges and opportunities Read More »
Dr. Ted W. Love elected new BIO Board chair
On June 5, 2023 , the Biotechnology Innovation Organization (BIO) announced its new Executive Committee Directors during the 2023 BIO International Convention taking place
Dr. Ted W. Love elected new BIO Board chair Read More »
New strategies for increasing diversity in clinical trials
Clinical trials are an essential part of the development and approval of new medical treatments. A growing issue within the clinical research community is
New strategies for increasing diversity in clinical trials Read More »
Enhancing public health preparedness through policy and partnership
“The policy environment is something that a lot of people seem to think is this separate, strange thing that has very little to do
Enhancing public health preparedness through policy and partnership Read More »
EU’s plan for new pharma regulations poses challenges for industry, say experts at BIO convention
A proposal to provide the first overhaul of European Union pharma regulation in 20 years takes some positive steps but would still leave a
Medicare confirms registry requirement for new class of Alzheimer’s drugs
A new class of Alzheimer’s drugs will be available to patients on Medicare – but only if the medicine has received “traditional approval” and
Medicare confirms registry requirement for new class of Alzheimer’s drugs Read More »
IRA means 40% reduction in new drugs over 10 years, report finds
The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected,
IRA means 40% reduction in new drugs over 10 years, report finds Read More »